Bunkerhill AVC vs ASSURE Wearable ECG

Tool B, the ASSURE Wearable ECG, prioritizes patient comfort and ease of use with its SensorFit Garment and mobile application, leading to high patient compliance with median wear times over 23 hours per day. While Tool A integrates with EHRs for clinician workflow, Tool B's strong emphasis on patient-centric design and demonstrated high adherence gives it an edge in overall usability across the care continuum.

Tool A, Bunkerhill AVC, offers broader opportunistic clinical value by leveraging existing chest CT scans to detect and quantify multiple cardiovascular calcifications (aortic, coronary, mitral annular) and assess bone density. This approach identifies at-risk patients who might otherwise be missed, enabling earlier intervention and improved outcomes, including a reported 44-percentage-point increase in statin prescription rates. Tool B provides continuous monitoring for already at-risk patients, but Tool A's ability to proactively screen for multiple conditions from routine imaging offers a more expansive impact on early disease detection.

Both tools require contacting for pricing, limiting transparency. However, Tool A, Bunkerhill AVC, has successfully led the submission for and secured a new national CMS reimbursement pathway for its AI-driven cardiovascular analysis on CT scans, effective April 1, 2026. This establishes a clear financial framework for health systems, making its value proposition more defined and accessible for adoption compared to Tool B, where specific pricing details and reimbursement pathways are not as explicitly outlined.

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Tool A integrates deeply with EHRs and clinical archives, enabling customizable AI agents for diverse workflows within health systems. Tool B provides a comprehensive remote patient data platform (Kestra CareStation) and supports integration with major healthcare IT standards like Epic, Cerner, PACS, FHIR, HL7 v2, DICOM, SNOMED, and ICD-10. Both are well-equipped for deployment in complex healthcare environments.

Tool A, Bunkerhill AVC, stands out with its 'generative AI platform, Carebricks, for clinical reasoning and action' and natural language processing capabilities. This allows health systems to rapidly build and deploy custom AI agents for a wide range of clinical and operational workflows, representing a broader and more foundational innovation in healthcare AI. While Tool B's wearable technology is innovative in its specific domain, Tool A's generative AI approach for workflow orchestration is a more expansive technological advancement.

Tool B, ASSURE Wearable ECG, explicitly outlines its support infrastructure, including a 24/7 ASSURE Helpline for both patients and providers, comprehensive Patient Handbooks, User Manuals, and 'ASSURE Assist services' for post-event support. Tool A's publicly available information does not detail its customer support or documentation, making Tool B the clear winner in this dimension due to its transparent and robust support offerings.